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Igor M SamokhvalovAbstract
Studying embryonic hematopoiesis is complicated by diversity of its locations in the constantly changing anatomy
and by the mobility of blood cell precursors. Embryonic hematopoietic progenitors are identified in traditional
in vivo and in vitro cell potential assays. Profound epigenetic plasticity of mammalian embryonic cells combined
with significant inductive capacity of the potential assays suggest that our understanding of hematopoietic
ontogenesis is substantially distorted. Non-invasive in vivo cell tracing methodology offers a better insight into
complex processes of blood cell specification. In contrast to the widely accepted view based on the cell potential
assays, the genetic tracing approach identified the yolk sac as the source of adult hematopoietic stem cell lineage.
Realistic knowledge of the blood origin is critical for safe and efficient recapitulation of hematopoietic development
in culture.
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All blood cells of adult organism are produced in the
process of hematopoiesis which depends entirely on the
ability of hematopoietic stem cells (HSCs) to self-renew
and differentiate into all hematopoietic cell lineages. In
mice, the whole population of adult HSCs is formed
during embryogenesis and first neonatal weeks [1]. This
process has been described in a number of detailed
reviews which reflect the current understanding of the
HSC development [2-5]. However, a closer look at ex-
perimental data reveals significant contradictions in the
current paradigm of hematopoietic ontogenesis, and
demands reassessment in view of the recent findings
[6-8]. This is especially important if the lessons learned
from studying the HSC development are meant to be
used for future clinical applications. This review is an
attempt of alternative interpretation of published ex-
perimental data.
Early mammalian development is highly regulative [9]
and it is difficult to determine how long this capacity is
operational in early ontogenesis. Isolated parts or tis-
sues of precirculation conceptuses have the ability to
adapt to the changed microenvironment by switching
to an alternative developmental pathway tissues. ThisCorrespondence: igors@gibh.ac.cn
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reproduction in any medium, provided the orcapacity therefore substantially complicates finding the
anatomical origin of mammalian hematopoiesis by
standard hematological approaches. However, practic-
ally all information about development of hemato-
poietic progenitors and HSCs is based on the analysis
of embryonic cell potentials in a number of in vivo and
ex vivo assays. Accumulating evidences on the extent
of cell plasticity [10-13] and striking ease of cell repro-
gramming [14-16] suggest that there might be a signifi-
cant gap between measured potential of a cell and its
fate in developing conceptus. The assays may lead to
artefactual inductions that change initial commitment
of a cell and promote specification in an alternative
direction. Moreover, the assays can selectively kill cer-
tain subsets of hematopoietic progenitors by imposing
a strong non-physiological stress. Mere dissociation of
embryonic tissue before the assay can induce profound
changes in cell behavior [17]. Due to their unsettled
epigenetic status embryonic cells are more vulnerable
than adult cells to various inducing events during the
potential assays. And from a practical point of view, it
is difficult to detect the induced cell plasticity event in
embryonic system due to the absence of defined start-
ing cell types.
Another critical problem is that analyzing cell potenti-
ality is often skewed towards conditionally pluripotent or
highly multipotent cells which may be present in concep-
tus tissues. These cells can give rise to hematopoieticl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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differentiation, and the term of the hematopoietic pro-
genitor or even the HSC might be falsely awarded to a
cell which is not committed to differentiate into blood
in vivo.
For molecular studies, the classical hematological
assays are valuable since they outline the emerging
potentials during progressive mesoderm specification.
However, the cell potential dynamics are unlikely to ac-
curately describe developmental processes. The potential
data may prove misleading if we are to recapitulate
in vitro the natural sequence of embryonic cell induc-
tions and maturations from such epiblast cell surrogates
as ES or iPS cells.
Terms and definitions
Controversy surrounding the issue of mammalian blood
origin to a large extent results from the confusion with
the understanding and interpretation of basic terms and
definitions. One of these, “definitive HSC”, has to desig-
nate cells which self-renew and produce committed
hematopoietic progenitors at a suitable site of hemato-
poiesis. Definitive HSCs (dHSCs) are detected using
their ability to serially repopulate normal, i.e. non-
immunodeficient or otherwise genetically compro-
mised, myeloablated recipients. However, it remains an
open issue that some fetal cells may display the HSC
potential even in a stringent repopulation assay but do
not function as dHSCs in situ. It has been difficult to
determine when dHSCs start to generate blood
lineages in conceptus due to retrospective way of the
HSC definition. In the repopulation assay tested cells
are introduced into the severely conditioned environ-
ment of mouse recipient and their progeny is traced
for several months to confirm the long-term repopula-
tion potential. It is possible that apparent stem cell po-
tential of a tested cell population is actually induced
within the recipient hematopoietic system and a few
newly generated HSCs are efficiently selected for sur-
vival. First dHSC potential is found at embryonic day
10.5-11.0 (E10.5-E11.0), when the low-level adult-
recipient repopulating activity is first detected in the
aorta-gonads-mesonephros (AGM) region [18]. How-
ever, there is no evidence that these cells actually
function as typical HSCs at this stage in vivo, i.e.
self-renew and clonally differentiate into a number of
blood lineages. On the contrary, blood cell generation
does not occur [19,20], and cell proliferation in general
has been found to be very low in the AGM region at
this stage [21]. At E11.5-12.5 dHSCs expand in fetal
liver and possibly in placenta. Again, we can say only
about the expansion of a potential, but not about the
expansion of the stem cell function. The fetal liver
hematopoiesis (mainly erythropoiesis) is substantiallyincreased at this stage, although this might be accom-
plished mainly by unipotent or oligopotent progenitors
lacking the crucial self-renewal capacity [2].
To circumvent the difficulty with staging the onset
of dHSC function, the term “HSC lineage” can be
introduced or redefined. In developmental hematology
this term describes all developmental history of strictly
defined dHSCs starting from the earliest mesodermal
precursor cells. Since early mammalian development is
highly regulative it is necessary to exclude the zygote,
blastomeres, inner cell mass (ICM) and epiblast cells
from the HSC lineage. The lineage includes commit-
ted toward hematopoiesis mesodermal cells in early
embryo, their progeny leading eventually to mature
stem cells and which can be called pre-HSCs (inter-
mediate cells ultimately giving rise to the initial dHSC
population) and two major subtypes – fetal and adult –
of dHSCs. Many members of the HSC lineage do not
possess the HSC potential and cannot function as stem
cells; they have to undergo specification, selection and
maturation to become fully operative dHSCs. In the
conceptus this lineage coexists with others, such as
primitive erythroblasts, macrophages and megakaryo-
cytes, and a number of definitive transient hematopoietic
progenitor lineages in yolk sac, fetal liver and other fetal
hematopoietic organs constituting the first wave of
definitive hematopoiesis [22]. The relationship between
all these conceptal hematopoietic cell lineages is unclear,
though recent cell tracing experiments point to the prob-
ability that all these lineages have common mesodermal
precursors [6,8].
Another specific term which needs clarification is “de
novo hematopoiesis”. The purpose of the term is to dis-
tinguish two distinct processes of blood cell formation:
the hematopoiesis itself, i.e. generation of blood cells
from an existing hematopoietic precursor, and differen-
tiation of the lateral mesoderm into first cells which
can be regarded as belonging to a blood cell lineage.
The obvious difficulty in the definition is the uncer-
tainty about criteria which can be used to define emer-
ging cells as hematopoietic. Perhaps induction of
molecular signatures similar to the early hematopoietic
triade [23] can be chosen to distinguish this type of
hematopoiesis. The term reflects an objective process of
primary blood generation in the conceptus, whereas the
expansion and maturation of newly formed hematopoietic
precursors can be defined as secondary developmental
hematopoiesis which is distinct from the “classical”
hematopoiesis initiated by mature hematopoietic progeni-
tors or dHSCs. De novo hematopoiesis can be regarded as
segregation of blood-committed cells from other mesoder-
mal precursors. By definition, de novo hematopoiesis is
always an autonomous process, whereas the secondary
and “the classical” types of hematopoiesis are mostly non-
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from the sites of the primary or de novo hematopoiesis.
Inadequate methodology
What an undifferentiated cell can do in an unnatural
environment seems to depend entirely on the conditions
used in an assay. A typical example is so-called random
commitment of adult HSCs in methylcellulose (Mtc)
cultures [24,25]. When challenged in vitro by a combin-
ation of exogenous cytokines, freshly isolated HSCs that
are capable of long-term multilineage repopulation of the
recipient's hematopoietic system can spontaneously
and randomly differentiate into lineage–committed
hematopoietic progenitors and generate corresponding
mature blood cells. Even highly purified HSCs easily form
colonies of differentiated hematopoietic cells both in
liquid and methylcellulose media supplemented with
hematopoietic cytokines. Evidently, isolation of the stem
cells from their native niche removes any inhibitory
signaling and restores their capacity to respond
to proliferation/differentiation cues. More than 90%
of single CD150+CD48─CD41─c-kit+Sca-1+Lin─ cells,
which are essentially pure HSCs (1 in 3 cells gave
long-term multilineage reconstitution) [26], formed
mainly CFU-mix (colony forming unit – mixed)
and CFU-GM (colony forming unit – granulocyte/
macrophage) in a standard Mtc assay [26,27]. Around
80% of CD34─KSL cells gave rise to colonies of differen-
tiated hematopoietic cells in the liquid cultures
supplemented with cytokines [28].
The potential of many early conceptus cells is essen-
tially conditional. E9.0 yolk sac cells do not repopulate
conditioned adult bone marrow, whereas they become
functional after injection into conditioned newborn fetal
liver [29,30]. Cells from the E8.0-E8.5 yolk sac were by
no means capable of rescuing hematopoiesis in irradiated
adult recipients, but they gained the long-term engraft-
ment activity after co-culture with the stromal cell line
derived from the AGM region [31]. Cells freshly isolated
from the paraaortic splanchnopleura (P-Sp) could not dir-
ectly engraft the bone marrow of adult immunodeficient
recipients, but they get a chance when cultured within the
explant for several days [32,33]. Clearly, in the search for
hematopoietic progenitors their putative precursors are
often forced to undergo additional development. Could it
occur also in the standard hematological assays?
There is direct experimental evidence of the gap be-
tween measured cell potential and the actual function
of the hematopoietic precursors in developing embryo.
Analyzed in an in vitro assay the hemangioblast poten-
tial was found mostly (75%) around the primitive
streak [34] at the stage at which the mesodermal
masses in the proximal yolk sac were clearlycommitted to hematopoiesis and largely segregated
from endothelial precursors located more distally in
the yolk sac [35,36]. Cell tracing experiments showed
the absence of any perceptible hemangioblasts activity
in vivo or in the cultured conceptus [6,37,38]. Appar-
ently, when mesodermal cells are subjected to high
concentration of VEGF and c-Kit ligand in culture,
they generate cell colonies capable to differentiate into
endothelial and blood cells, but in reality these two
cell lineages segregate immediately after the emergence
from the primitive streak. Differentiated definitive
erythroid progenitors (CFU-E, colony forming units –
erythroid) can be detected in the yolk sac already at
E8.5 by standard methylcellulose assay [39]. The pres-
ence of these progenitors is a clear sign of terminal
stages of active erythropoiesis, but the first mature de-
finitive erythrocytes are detected in mouse embryo
almost 4 days later [40-41]. The most feasible explan-
ation is that some immature hematopoietic precursor
cells which are not actually producing mature blood
cells can nevertheless survive in the assay and differ-
entiate into CFU-Es. These precursors in real develop-
ment would need the environment of fetal liver to
develop into the erythroid progenitors and possibly
into other hematopoietic progenitors including HSCs.
The mentioned above notion of the absence of active
hematopoiesis in the AGM region highlights the differ-
ence between the HSC potential and the HSC function.
Fetal HSCs are known to actively proliferate [1] and
normally stem cell proliferation is accompanied by their
differentiation into committed hematopoietic progeni-
tors. The failure of hematopoietic progenitor generation
in the AGM region was explained by incompatibility of
de novo generation of dHSCs with the secondary
hematopoiesis [19]. Alternatively, the AGM cells that
display stem cell potential in conditioned adult recipi-
ents may not be actually capable of performing the
HSC function in embryo, but rather have reached an
epigenetic status compatible with adult bone marrow
inductive environment which allows them to survive
and produce differentiated multilineage progeny. It is
possible that only a very small fraction of the trans-
planted cell population is selected to survive and adapt
to assay’s microenvironment. Earlier precursor cells
may be not prepared yet to survive the assays environ-
ments because they are not capable yet to recognize
the maintenance or survival signals. The maturation, or
directed epigenetic changes, would make them more
suitable for the assays’ challenges. In this view, the po-
tential assays do not study the progenitor dynamics, in-
stead they expose the sequence of epigenetic changes
in the developing immature precursor cells which can-
not be characterized yet as hematopoietic progenitors
or stem cells.
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trate on discerning the “cellular pathways” which start
from the emergence of lateral mesoderm and culminate
in the formation of functional in situ dHSCs. The path-
ways have to be revealed through the analysis of the
crosstalk between particular phenotypic and epigenetic
state of the hematopoietic cells and corresponding in-
ductive environments in the conceptus. An appropriate
methodology for this is genetic cell tracing analysis
performed in vivo, or in the long-term culture of mid-
gestation mouse conceptuses, or during in vitro differen-
tiation of human pluripotents cells.
Problems with intraembryonic sites of de novo
hematopoiesis
The central role in the HSC ontogenesis has been
ascribed to the paraaortic splanchnopleura (P-Sp) which
later transforms into the AGM region [42]. It is generally
thought that the intra-embryonic HSCs develop in close
association with the ventral wall of the dorsal aorta, and
perhaps with the endothelium of vitelline/umbilical ar-
teries and placental vessels. This de novo hematopoiesis
is believed to happen in hematopoietic intra-aortic clus-
ters (HIACs) which are seen to be attached to the endo-
thelium of big vessels during midgestation in mice and
5th week of gestation in human. Direct involvement of
endothelial cells in the process has been postulated [43],
and the concept of hemogenic endothelium has been
developed [44,45]. In a slightly different view, the au-
tonomous source of the HSC lineage lies beneath dorsal
aorta in subjacent mesenchyme [46], or in subaortic
patches [47], so that developing pre-HSCs migrate to-
wards lumen of aorta and eventually formed hemogenic
clusters. The hemogenic endothelium hypothesis is cur-
rently getting wider support [4] though there is probably
no big difference between these two models. The ances-
tral P-Sp region was reported to contain some cells of
the HSC lineage, which seem to arise there autono-
mously. These cells are believed to become committed
to develop into cells with some repopulation potential
[32,33] at the time when aortic vasculogenesis takes
place [40]. This means that some mesodermal precur-
sors belonging to the HSC lineage could perform the in-
corporation into the endothelial layers of the aorta, and
then would “transdifferentiate” into HIACs. However,
this transdifferentiation would happen at the moment
when dorsal aorta and other major vessels sustain a vig-
orous extension and remodeling in addition to the in-
duction of intensive angiogenesis into adjacent tissues
[48]. It might be possible that cell clusters forming inside
of big vessels, instead of being a product of local prolif-
eration of hemogenic endothelium, are in fact involved
in the development of vascular system. Indeed, endothe-
lial cell proliferation in the floor of midgestation dorsalaorta was reported to be minimal if not completely ab-
sent [49]. The emergence of HIACs in zebrafish was re-
cently suggested to be associated with vascular
remodeling [50], and it still remains to be demonstrated
whether HIACs contain cells with the dHSC potential.
There are two major problems with depicting the
P-Sp as an early source of the HSC lineage. First, there
is a substantial risk of primordial germ cells (PGCs)
being involved in the manifestation of progenitor or
stem cell activity. These cells at E8.5-E9.0 are located
in the caudal part of P-Sp (where most of blood clo-
nogenic activity was detected [32]) being on the migra-
tion route from mesodermal layer into definitive
endoderm of primitive gut [51,52]. The PGCs are con-
ditionally pluripotent cells and have potential to differ-
entiate in vitro into multiple hematopoietic lineages
[53,54]. One cannot therefore exclude a possibility that
PGCs can display a HSC potential after being intro-
duced into conditioned immunodeficient recipient. It is
probably not a simple coincidence that PGCs arrive
into the AGM region between E10.5-E11.0 [55] when
the first HSC potential is detected there. Similar to
primitive blood cells the PGCs originate in extra-
embryonic mesoderm and share with developing
hematopoietic cells the expression of such markers as
c-Kit [51], CD31 (PECAM) [56,57], integrin β1 [58]
and CXCR4 [59]. It is unclear to which extent the
HSC potential can be attributed to PGC contamination
in the E10.5-E11.0 AGM region since it is difficult to
reliably separate HSC and PGC lineages at this stage.
There are other cells in early embryo which could
develop HSC potential in hematopoietic assays. Mouse
embryo gastrulation starts at E6.5 and continues until
around E10.5, when caudal neuropore is finally closed
[60]. It is unclear whether primitive streak cells are
capable to display a hematopoietic potential in
hematological assays, but it is feasible that cells newly
derived from epiblast may be prone to show a signifi-
cant multipotentiality, even though they has been charac-
terized as “committed” to one or another cell fate [61,62].
Primitive streak cells are also located in the caudal part
of P-Sp and it is very difficult to separate them from the
lateral mesoderm layer in the P-Sp explants. They might
therefore contribute to the HSC/progenitor potential of
intraembryonic cells.
The pivotal experiments supporting the AGM’s role as
an autonomous source of dHSCs includes short-term
ex vivo organ culture of the AGM, fetal liver and the
yolk sac [63]. The AGM showed an extraordinary pro-
pensity for the expansion of the E10.5-E11.0 dHSC
potential during the explant culture compared to fetal
liver and yolk sac. Since the AGM microenvironment is
not destroyed in the briefly cultured explant, one can
think that most of HSC-inducing signals are preserved,
Figure 1 Yolk sac blood cells at E8.25-E8.5. Hematopoietic cells were visualized by Runx1/LacZ staining. (a) “Blood island” - like cell
aggregations appear in the proximal yolk sac at around the start of blood circulation. The red arrow points to blood cells on their way through
vitelline vein into embryonic vasculature. (b) Dense cell clusters in the proximal region of the yolk sac resist the circulation drive for some period
of time. (c) In pre-circulation conceptus blood cells start to move distally before the yolk sac vascular plexus fuses with the embryo vasculature.
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stem cell potential. This was the reason to suggest that
the region was an autonomous intraembryonic site of
dHSCs de novo generation. However, when an early E9.5
P-Sp/AGM was subjected to the explant culture no ac-
cumulation of the stem cell potential was observed [64].
If the AGM region is the autonomous source of HSCs, it
would be reasonable to assume that the E9.5 explants
should also generate dHSC potential in the same culture
conditions. A number of plausible explanations can be
put forward to explain the absence of the potential at
the end of the E9.5 AGM explant culture, but if the
“nascent pre-HSCs” are already present in the ancestral
E8.0 P-Sp region [33], it would be difficult to accept
them without reservations. The simplest and therefore
most plausible explanation (apart from the PGC involve-
ment) is that the stem cell precursors are not yet present
in the AGM region before E9.5 but appear there later, in
the period between E9.5 and E10.5, most likely immi-
grating from the yolk sac. This would explain why yolk
sac does not accumulate the stem cell potential in the
explant cultures [63,64]: pre-HSCs are leaving the yolk
sac environment probably because it is not suitable for
induction or maintenance of the dHSC potential [36].
If dHSCs emerge from the floor of the dorsal aorta,
they would require some local inductive signals emanat-
ing from adjacent intraembryonic tissues. However,
HIAC-like cell clusters presumably possessing the dHSC
potential appear at the same stages in umbilical and vi-
telline arteries [49,65-67]. Even though the vessels are
directly connected to the dorsal aorta, they do not have
the same potentially inductive tissues nearby. This would
invoke two different mechanisms of de novo generation
of dHSCs, unless HIAC cells can dissociate from the
clusters, “roll” along the vasculature and re-attach to
other endothelial beds.The yolk sac reloaded
A number of recent publications may change the current
understanding of developmental hematopoiesis [6-8].
The rodent visceral yolk sac is a very prominent part of
the conceptus and provides mechanical protection to
the fetus at later stages of development and birth. Early
in development, immediately after its formation, the vis-
ceral yolk sac serves as a primitive placenta for the short
period of time [68]. The early yolk sac is formed by es-
sentially simple bilaminar tissue consisting of extraem-
bryonic lateral mesoderm and an adjacent layer of
primitive visceral endoderm [35]. The yolk sac is quickly
vascularized, and initial simple vascular plexus becomes
fused with the embryo vasculature at the onset of blood
circulation. When the circulation starts at E8.25-E8.5,
the yolk sac vasculature begins to be remodeled eventu-
ally forming the yolk sac vascular system.
During gastrulation the extraembryonic mesoderm
moves towards the ectoplacental cone and builds up sig-
nificant cell masses in the proximal yolk sac region at
around E7.5. These mesodermal cell masses accumulate
globin during the day 9 of gestation (E8.0-E9.0) and de-
velop into structures which are called the “blood islands”
which look like reddish spots in the proximal part of dis-
sected yolk sac. It has long been thought that inner cells
of the islands become blood cells, whereas the external
ones develop into endothelium [69]. This, however, may
not be the case. Detailed fluorescent immunohistochem-
ical analysis of the early yolk sac revealed quite a differ-
ent picture of extraembryonic mesoderm specification
[70]. The proximal mesodermal cell masses turned out
to specialize almost exclusively into blood cells. Appar-
ently, the proximal yolk sac is the first anatomical site of
active de novo hematopoiesis in the conceptus. Emerging
more distally vascular plexus was found to expand prox-
imally and envelop emerging blood cells squeezing them
Figure 2 Mesodermal cell masses in the proximal yolk sac co-express Runx1 and VE-cadherin. Two upper panels show the flow cytometry
analysis of pooled cells from eight E7.5-8.0 yolk sacs. Two lower panels demonstrate connection between the level of the Runx1 expression and
the efficiency of cell labeling in the cell tracing studies [6].
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blood islands probably correspond to big cell aggrega-
tions that become later vascularized and release blood
cells into developing vascular plexus (Figure 1a). Some
cell clusters still look quite dense even when yolk sac
becomes well vascularized (Figure 1b). These transient
aggregations may give rise to Runx1high clusters of de-
finitive precursor cells, which presumably contain mem-
bers of the HSC lineage [6]. A great majority of cells
arising from the proximal mesodermal masses are primi-
tive erythroblasts, and they start to spread distally before
blood circulation is initiated (Figure 1c). These cells
might be pushed by the large number of blood islandcells which become non-adherent at E8.0-E8.5. Circula-
tion significantly increases the spreading, but for some
period of time most of red blood cells are still retained
within the yolk sac [71], which suggests that develop-
ment of vasculature in the yolk sac substantially out-
paces it in the embryo proper. Importantly, the cells
with the definitive progenitor potential have significantly
higher affinity to the yolk sac microenvironment at E9.5-
E10.5 suggesting that the yolk sac works as temporary
pre-liver niche for immature blood cells precursors [71].
Some of those precursors can be visualized by staining
with CD41, and clusters of CD41bright cells can be seen
at the early somite stage within blood island [70]. It is
Fetal LiverVasculatureBlood IslandsMesoderm











Figure 3 Migration of blood cell precursors in the conceptus and the dynamics of their developmental potential. Red cells are shown by
open circles. Fenestrated endothelium of fetal liver sinusoids promotes the entry of hematopoietic progenitors into the first extravascular niche.
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Runx1high cell aggregates detected at the same stage and
in the same region by LacZ staining [6].
The proximal mesodermal cell masses recently were
shown to coexpress a number of hematopoietic and
endothelial markers [8,72]. Practically all Gata1- and
majority of Runx1-positive cells in the mesodermal
masses at the neural plate stage transiently coexpress
VE-cadherin [8,72,73], the most specific marker of endo-
thelial lineage. Gata1 and Runx1 are the key transcrip-
tion factors for erythroid and entire definitive
hematopoietic development, respectively [74,75]. Slightly
later at E7.75 (head hold stage), an embryonic globin
marker of primitive erythroblasts is also transiently
co-expressed with VE-cadherin apparently in the nascent
embryonic red blood cells. It is unclear what function,
if any, VE-cadherin is playing in the developing
hematopoietic lineage, but the co-expression of the
hematopoietic factors with VE-cadherin in non-endothelial
cells suggests that unique epigenetic changes happen dur-
ing de novo hematopoiesis. VE-cadherin+Runx1+ cells were
found to be the earliest definitive hematopoietic precursors
[8] and the co-expression is sustained for some period of
time - about half of Runx1+ YS cells are still VE-cadherin-
positive at the neural fold stage (Figure 2). Interestingly,
only about 25% of all Runx1-positive cells at the neural
plate can be arbitrarily qualified as Runx1high (Figure 2)
which underscores cell heterogeneity of the developing
blood islands. It remains to be investigated whether thelevel of Runx1 expression has a functional significance,
but the Runx1high cells as preferable targets for
Cre-dependent recombination in the Runx1-based cell
tracing (Figure 2) eventually develop into adult
hematopoietic cells including dHSCs [6,8].
It is reasonable to assume that during hematopoietic
specification the mesodermal masses are epigenetically
distinct from both truly hematopoietic and endothelial
cells as well as from “unspecified” or hemangioblast-like
lateral mesoderm. The proximal yolk sac mesodermal
masses therefore emerge as a unique cell population
within developing conceptus. The endothelial marker ex-
pression at an early phase of mesoderm differentiation
might reflect the default endothelial commitment of
extraembryonic mesoderm [76], being a transient “left-
over” from a more primitive developmental program
[77], or it manifests yet unknown regulatory function of
some endothelial markers in the hematopoietic develop-
ment [78].
At about the same time the HSC lineage is being
induced in the extraembryonic mesoderm cell masses
[6,8]. We do not know the characteristics of first cell
belonging to the lineage, but it is tempting to see them as
primitive phagocytic or macrophage-like cells. The early
yolk sac was recently shown to be an independent source
of microglia and skin dendritic cell lineages [7,79], and it
would not be surprising if other adult macrophage
lineages arise autonomously in the extraembryonic meso-
derm. Along with oxygen supply, the embryonic blood
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clear up apoptotic cells in embryo [80,81]. These phago-
cytes may emerge in blood islands as not fully functional
primitive macrophages or macrophage precursors, and in
contrast to the erythroblasts some of them could maintain
or develop multipotentiality [82]. In this view, the
intraaortic hemogenic clusters may reflect the process of
macrophage extravasation [6] induced by such inflamma-
tory factors as prostaglandin PGE2 [83], which have been
shown to enhance the HSC generation in the AGM region
of zebra fish and may also be able to do it in mammalian
embryo [84]. Type II vasculogenesis [85] may be assisted
by monocytes/macrophages as they are thought to be able
to incorporate into endothelial layers [86,87].
In addition to HSC lineage cells, the progeny of the
yolk sac mesodermal masses also includes some emer-
ging hematopoietic progenitors that have a limited self-
renewal potential [88,89]. These progenitors may be
responsible for production of definitive erythrocytes
beginning from E12.0 and also involved in the in vivo
production of first definitive myeloid cells.
The inability of the yolk sac cells to demonstrate the
dHSC potential can be attributed to the essential imma-
turity of early members of the HSC lineage that arise
during de novo hematopoiesis. In order to understand
the HSC development, more attention should be direc-
ted towards the proximal extraembryonic region of the
visceral yolk sac. Learning about in vivo dHSC develop-
ment will be undoubtedly instrumental in the design of
efficient, reproducible and safe protocols for in vitro
HSC generation.
Conclusions
Current picture of the mammalian blood development
was created using methods intended for studying adult
hematopoiesis. It seems that most of controversies
in developmental hematology arise from the excessive
reliance on measuring cell potentials rather than cells
fates. Unsettled epigenetic status of early embryonic cells
makes them prone to show a variety of potentials which
do not reflect the actual process of hematopoietic onto-
genesis. Therefore, we can hardly attribute distinct
hematopoietic phenotypes of adult hematology to
hematopoietic precursors in the developing conceptus.
Due to overbearing cell potential research, the role of
the yolk sac in creation of HSC lineage was seriously
underestimated by standard cell potential assays. As
shown by the cell tracing studies, the proximal mesoder-
mal masses of yolk sac may represent a unique cell
population of the single hematopoietic origin in mam-
mals. In the new emerging picture of hematopoietic
ontogenesis the AGM region, umbilical/vitelline arteries
and placental vasculature are not autonomous sources of
definitive hematopoiesis. Instead, they operate astransient intravascular niches for developing HSC
lineage (Figure 3). The first extravascular niche is
formed within the fetal liver which functions as the first
bona fide hematopoietic organ in mammalian
ontogenesis.
The efficient protocol for generating the HSC potential
in vitro is unlikely to be established empirically. It is
hardly the way to translate our studies into safe and re-
producible clinical applications. Accepting the pivotal
role of yolk sac as the single origin of adult-type
hematopoiesis is the key for developing the recapitula-
tion strategy for efficient production of dHSC in well-
defined artificial microenvironment.
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